BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening TrialExtensive Validation of BioMark's Comprehensive Metabolic Panel in German 10,000-Participant HANSE Study, within the context of an international consortium supported under the EUREKA Network.October 07, 2025 8:30 AM EDT | Source: BioMark Diagnostics, Inc.Vancouver, British Columbia--(Newsfile Corp. - October 7, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading dev ...